FI900492A0 - Gemfibrozilkompositioner med utvidgad frigivningsprofil. - Google Patents

Gemfibrozilkompositioner med utvidgad frigivningsprofil.

Info

Publication number
FI900492A0
FI900492A0 FI900492A FI900492A FI900492A0 FI 900492 A0 FI900492 A0 FI 900492A0 FI 900492 A FI900492 A FI 900492A FI 900492 A FI900492 A FI 900492A FI 900492 A0 FI900492 A0 FI 900492A0
Authority
FI
Finland
Prior art keywords
utvidgad
gemfibrozilkompositioner
frigivningsprofil
med
granulation
Prior art date
Application number
FI900492A
Other languages
English (en)
Finnish (fi)
Inventor
Isaac Ghebre-Sellassie
Mahdi Fawzi
Uma Iyer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of FI900492A0 publication Critical patent/FI900492A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI900492A 1989-02-02 1990-01-31 Gemfibrozilkompositioner med utvidgad frigivningsprofil. FI900492A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/305,083 US4925676A (en) 1989-02-02 1989-02-02 Extended release gemfibrozil composition

Publications (1)

Publication Number Publication Date
FI900492A0 true FI900492A0 (fi) 1990-01-31

Family

ID=23179257

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900492A FI900492A0 (fi) 1989-02-02 1990-01-31 Gemfibrozilkompositioner med utvidgad frigivningsprofil.

Country Status (20)

Country Link
US (1) US4925676A (zh)
EP (1) EP0381218B1 (zh)
JP (1) JPH02235810A (zh)
CN (1) CN1044590A (zh)
AT (1) ATE88888T1 (zh)
AU (1) AU624217B2 (zh)
CA (1) CA2009134A1 (zh)
DE (1) DE69001487T2 (zh)
DK (1) DK0381218T3 (zh)
ES (1) ES2055176T3 (zh)
FI (1) FI900492A0 (zh)
HU (1) HU204194B (zh)
IE (1) IE900372L (zh)
IL (1) IL92995A0 (zh)
MY (1) MY104899A (zh)
NO (1) NO900483L (zh)
NZ (1) NZ232322A (zh)
PH (1) PH26308A (zh)
PT (1) PT93028A (zh)
ZA (1) ZA90778B (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1246382B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
EP0462066A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Amorphous gemfibrozil
EP0462067A1 (en) * 1990-06-15 1991-12-18 Warner-Lambert Company Gemfibrozil formulations
EP0475894A1 (en) * 1990-08-27 1992-03-18 Warner-Lambert Company Gemfibrozil formulations
US5102668A (en) * 1990-10-05 1992-04-07 Kingaform Technology, Inc. Sustained release pharmaceutical preparation using diffusion barriers whose permeabilities change in response to changing pH
CZ286723B6 (cs) * 1991-01-30 2000-06-14 The Wellcome Foundation Limited Tablety dispergovatelné ve vodě
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
EP0614358A1 (en) * 1991-11-26 1994-09-14 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
US5492700A (en) * 1991-11-26 1996-02-20 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
US5358723A (en) * 1991-11-26 1994-10-25 Warner-Lambert Company Process and composition for the development of controlled release gemfibrozil dosage form
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
HU212428B (en) * 1994-05-13 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process to prepare pharmaceutical compositions containing gemfibrozyl
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) * 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
EP1572190B1 (en) * 2002-12-17 2007-04-18 Abbott GmbH & Co. KG Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof
US20070212416A1 (en) * 2004-06-10 2007-09-13 Glatt Air Techniques, Inc. Controlled Release Matrix Pharmaceutical Dosage Formulation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US4291016A (en) * 1976-07-27 1981-09-22 Sandoz Ltd. Enteric coated mixture of 4-(2-hydroxy-3-isopropylamino-propoxy) indole and sodium lauryl sulphate
US4195084A (en) * 1977-01-07 1980-03-25 Eli Lilly And Company Taste-stable aqueous pharmaceutical suspension of tall oil sitosterols and a method for the preparation thereof
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
JPS618A (ja) * 1984-06-09 1986-01-06 Sawai Seiyaku Kk ニフエジピン含有製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
EP0212747B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release and immediate release
US4778676A (en) * 1985-12-20 1988-10-18 Warner-Lambert Company Confectionery delivery system for actives
IL81419A0 (en) * 1986-01-30 1987-08-31 Syntex Inc Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation
US4716033A (en) * 1986-03-27 1987-12-29 Warner-Lambert Company Medicament adsorbates with surfactant and their preparation
US4816264A (en) * 1986-06-06 1989-03-28 Warner-Lambert Company Sustained release formulations
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
AU1422388A (en) * 1987-01-27 1988-08-10 Warner-Lambert Company Lipid regulating compositions

Also Published As

Publication number Publication date
AU624217B2 (en) 1992-06-04
NZ232322A (en) 1991-02-26
IL92995A0 (en) 1990-09-17
HUT52952A (en) 1990-09-28
EP0381218A3 (en) 1990-12-05
DE69001487D1 (de) 1993-06-09
NO900483L (no) 1990-08-03
CA2009134A1 (en) 1990-08-02
MY104899A (en) 1994-06-30
JPH02235810A (ja) 1990-09-18
DK0381218T3 (da) 1993-06-01
PT93028A (pt) 1990-08-31
ZA90778B (en) 1991-10-30
US4925676A (en) 1990-05-15
EP0381218A2 (en) 1990-08-08
AU4899090A (en) 1990-08-09
HU204194B (en) 1991-12-30
ES2055176T3 (es) 1994-08-16
CN1044590A (zh) 1990-08-15
HU900640D0 (en) 1990-04-28
EP0381218B1 (en) 1993-05-05
NO900483D0 (no) 1990-02-01
DE69001487T2 (de) 1993-08-26
IE900372L (en) 1990-08-02
PH26308A (en) 1992-04-29
ATE88888T1 (de) 1993-05-15

Similar Documents

Publication Publication Date Title
FI900492A0 (fi) Gemfibrozilkompositioner med utvidgad frigivningsprofil.
FR2685869B1 (fr) Compositions therapeutiques a base d'inhibiteurs mixtes de la no synthase et de la cyclooxygenase.
KR910000107U (ko) 슬라이드 파스너의 해제를 저지하는 장치
NO900338D0 (no) Fremgangsmaate for befestigelse av en slange til en nippelog en derved tilveiebragt forbindelse.
NO891906L (no) Fremgangsmaate for fremstilling av et harpiksadsorbat av ranitidin.
BR8901139A (pt) Parafuso de retencao com esfera de engate
DE69003467D1 (de) Schnellvervindungs- und Schnellöse-Kupplung.
DK180389A (da) Fremgangsmaade til desinfektion af lokaler samt anlaeg til udoevelse af fremgangsmaaden
NO852200L (no) Fremgangsmaate for bestemmelse av plasseringen av perforeringer i et broennforingsroer.
ES2088956T3 (es) Estructura de tableta multifraccionable.
NO904513L (no) Fremgangsmaate for fremstilling av et naeringsmiddel.
NO900622D0 (no) Fremgangsmaate for anrikning av stoev dannet i en kupolovn.
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
FR2624012B1 (fr) Nouvelles compositions pharmaceutiques a action hypnotique a base d'hydrate de chloral
AU558587B2 (en) Antiinflammatory composition of inositol and piroxicam
BE856849A (fr) Composition pharmaceutique a base d'organophosphate et de sulfoxyde
FR2621368B1 (fr) Joint homocinetique du type tripode a retenue axiale
NO920098D0 (no) Fremgangsmaate for fremstilling av kulefanger samt anvendelse av saadan kulefanger
TR25109A (tr) DüZ PARCALARIN TEKLESTIRILMESINE MAHSUS USUL VE TERTIBAT
IT1237705B (it) Dispositivo per il collegamento di un condotto con possibilita' di distacco.
FR2665164B1 (fr) Compositions aqueuses polymerisables a base d'un ester d'alcoxyalkyle et preparation dudit ester d'alcoxyalkyle.
USD282085S (en) Hexagonal board for a game
USD265855S (en) Marker lamp lens
USD308551S (en) Game board
GB2201591B (en) Analgesic antipyretic and anti-inflammatory compositions.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: WARNER-LAMBERT COMPANY